16th EORTC - NCI - AACR Symposium

July 19, 2004

The revolution in understanding the molecular basis of cancer has lead to the discovery and development of numerous innovative agents - 'designer' diagnostics, new prognostic tests, 'smart' drugs and other entirely novel ways of tackling cancer.

To bring these new developments to patients as quickly and efficiently as possible requires international collaboration, early and optimal exchange of information, good quality translational research, efficient drug development and large prospective clinical trials.

Three of the world's leading cancer organisations:

  • The European Organisation for Research and Treatment of Cancer;
  • The USA's National Cancer Institute;
  • The American Association for Cancer Research;

    will join forces in Geneva from 28 September to 1 October to provide a platform for presentation of the latest findings in drug research and development to around 2,000 international experts in the field.

    All data at the four-day meeting are being presented for the first time.

    We welcome the media to the symposium. Every session is open to journalists and registration is free to bona fide media presenting official press credentials, or a letter from the editor of the journal they represent stating that they are being commissioned to write a report for publication.

    A media centre with computing, fax, photocopying and free international phone and internet connections will be available.

    NB: the official language of the symposium is English and all press materials will be in English.

    To register: contact Margaret Willson for a registration form or download one from the conference website.
    -end-
    More information on the programme, a registration form and details of the media policy are available on the EORTC conference website: http://www.fecs.be/Conferences/ena2004/index.shtml

    Hotel accommodation can be booked through:
    SYMPORG S.A.
    7, avenue Krieg
    CH-1208 Geneva - Switzerland
    primola.nicole@symporg.ch
    Tel: 41-22-8398484
    Fax: 41-22-8398485


    (NB: book by 1 September if you want accommodation at the conference hotel - the only hotel close to the centre).

    European Organisation for Research and Treatment of Cancer

    Related Cancer Articles from Brightsurf:

    New blood cancer treatment works by selectively interfering with cancer cell signalling
    University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

    UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
    A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

    Breast cancer treatment costs highest among young women with metastic cancer
    In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

    Cancer mortality continues steady decline, driven by progress against lung cancer
    The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

    Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
    Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

    Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
    The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

    Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
    Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

    More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
    An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

    New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
    Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

    American Cancer Society outlines blueprint for cancer control in the 21st century
    The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

    Read More: Cancer News and Cancer Current Events
  • Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.